- You are here:
- Home »
- Blog
Myeloma Maintenance- Revlimid Skin Patch
“…new treatment formulation delivered through a skin patch, maintaining an optimal blood level of the medicine (revlimid) for prolonged periods of time.” Low-dose multiple myeloma maintenance
Continue readingMultiple Myeloma Therapy- Celastrol/Thunder God Root-
“our results reveal the effects of celastrol on proteasome activity in Multiple Myeloma cells and shed light on the underlying mechanisms of its anticancer activity…” Where is it written
Continue readingMultiple Myeloma Treatment- Medical Health Care Records are KEY!
“Managing your health care records can be complicated, especially if you’re juggling information from several different medical providers and other sources…” Yet another example of
Continue readingMultiple Myeloma Survival- Mind-Body Therapy Beats Relapse?
COLUMBUS, Ohio – A psychological intervention program designed for breast cancer patients reduces the risk of dying if the cancer recurs, new research shows. The study is the latest in a series
Continue readingAllogeneic SCT for Myeloma “Curative Potential” for high-risk MM- REALLY?
for patients with high-risk MM who have a poor long-term prognosis, allo-SCT may be a strong consideration in their initial course of therapy or in first relapse after chemotherapy I am a long-term MM
Continue readingMultiple Myeloma Diagnosis- Integrative Diet, Exercise, Supplementation
“…achieving CR after HDT/SCT (ASCT) is the most important prognostic factor in Multiple Myeloma, even after long-term follow-up…” David, I have had full blown multiple myeloma
Continue readingEffective anti-Multiple Myeloma Therapy- Exercise
Exercise may have yet another benefit – the right amount at the right time could make multiple myeloma (MM) treatments such as radiation and chemotherapy more effective…” The many studies
Continue readingMultiple Myeloma Treatment- Financial Burden, OOP Costs
However, over time, patients with multiple myeloma incur more OOP costs. Accumulated OOP costs for 3 years following diagnosis was $9127 for patients with multiple myeloma. First some bad news and then
Continue readingTransplant Ineligible Myeloma- Darzalex (DRd)
“daratumumab was approved for use in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation” There’s
Continue readingNon-Secretory Myeloma “Survived Significantly Longer than Secretors”
“The non-secretory survived significantly longer that the secretors, median 46 months versus 21 months (p less than 0.01).” Early detection is a critical prognostic indicator in all cancers.
Continue readingMultiple Myeloma Diagnosis- “Why Me?” and Spirituality
“Spirituality is understood to be a “personal search to understand final questions about life, its meaning, its relationship to sacredness or transcendence..” If you have been diagnosed with
Continue readingMyeloma- ASCT = Chemo Fatigue not MM
“Fatigue ranks as perhaps the most prevalent of cancer complaints — studies over the past two decades have confirmed it as a significant problem during and for some years after treatment ends…” In
Continue reading